Pledge on 1.75 cr Thyrocare shares released by Catalyst Trusteeship
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.6 pts more than Nifty Microcap 250 and 5.7 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Catalyst Trusteeship Ltd, debenture trustee for API Holdings, released pledge on 1,75,00,000 equity shares (about 10.99% of capital) of Thyrocare Technologies on August 11, 2026. Pledgor was Docon Technologies. Post-release, encumbered shares fell from 9.69 crore to 7.94 crore shares, with encumbrance percentage dropping from 60.75% to 49.78% of diluted capital.
Reduces encumbered holding on Thyrocare shares; pledge release on behalf of API Holdings debenture holders eases a security overhang.